SEC Comment Letter for KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880) (KZIA) — Jul 31, 2008

KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880)
Date: July 31, 2008 · CIK: 0001075880 · Accession: 0000000000-08-038207

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

July 14, 2008

Author

Joel Parker

Form

UPLOAD

Company

KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880)

Letter

Mail Stop 6010 Via Facsimile and U.S. Mail July 14, 2008 Mr. Christopher Naughton Managing Director Novogen Limited 140 Wicks Road North Ryde, New South Wales 2113, Australia

Re: Novogen Limited Form 20-F for fiscal year ended June 30, 2007 File No. 0-29962

Dear Mr. Naughton:

We have completed our review of your Form 20-F and have no further comments at this time.

Sincerely,
Joel Parker
Branch Chief

Show Raw Text

Mail Stop 6010
Via Facsimile and U.S. Mail

                                                                                                July 14, 2008

Mr. Christopher Naughton
Managing Director
Novogen Limited
140 Wicks Road
North Ryde, New South Wales 2113, Australia

Re:      Novogen Limited
Form 20-F for fiscal year ended June 30, 2007
File No. 0-29962

Dear Mr. Naughton:

We have completed our review of your Form 20-F and have no further comments
at this time.

Sincerely,

Joel Parker
Branch Chief

SecProbe.io